Answers are grounded in this paper and cite their sources.
Objective. To analyze the therapeutic efficacy of the combined use of NOVACUTAN YBio and SBio drugs for the correction of a wide range of dermatological disorders. Based on the data obtained, we recommend the inclusion of these products in post-procedural rehabilitation after aggressive cosmetic procedures (laser resurfacing, chemical peels), as well as for dyschromia, signs of photoaging, decreased skin tone and turgor, dull uneven complexion, dehydration and peeling of the epidermis, and skin microrelief disorders. Materials and methods. Clinical experience in the use of NOVACUTAN YBio/SBio and NOVACUTAN BTA exoprotectors according to the «Beaty flash» and «High-light» protocols. Results. Injectable exoprotectors are effective as a therapeutic agent for repairing photo-damaged skin, as well as for protecting it from exposure to light, including UVA and UVB rays. Conclusion. Based on the results obtained, we recommend using exoprotectors during the recovery period after aggressive cosmetic procedures, as well as as a therapeutic agent against photoaging of the facial skin.
No takes yet. Share an insight, caveat, or question.
Gazitaeva et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: